Nonionic Surfactant Vesicles in Ocular Delivery: Innovative Approaches and Perspectives

@article{Sahoo2014NonionicSV,
  title={Nonionic Surfactant Vesicles in Ocular Delivery: Innovative Approaches and Perspectives},
  author={Ranjan Ku. Sahoo and Nikhil Biswas and Arijit Guha and Nityananda Sahoo and Ketousetuo Kuotsu},
  journal={BioMed Research International},
  year={2014},
  volume={2014}
}
With the recent advancement in the field of ocular therapy, drug delivery approaches have been elevated to a new concept in terms of nonionic surfactant vesicles (NSVs), that is, the ability to deliver the therapeutic agent to a patient in a staggered profile. However the major drawbacks of the conventional drug delivery system like lacking of permeability through ocular barrier and poor bioavailability of water soluble drugs have been overcome by the emergence of NSVs. The drug loaded NSVs… Expand
Niosome in Ocular Drug Delivery: An Update Review
-With the recent advancement in the field of ocular therapy, drug delivery approaches have been superior to a new concept in terms of nonionic surfactant vesicles (NSVs), that is, the ability toExpand
Emerging potential of niosomes in ocular delivery
TLDR
Challenges and barriers for ocular drug delivery, various transporters and receptors present in the ocular region for the transportation of therapeutics as well as nutrients, and various method of preparations, loading methods and application potential of niosomes in ophthalmic drug delivery are revealed. Expand
Niosomal Drug Delivery Systems for Ocular Disease—Recent Advances and Future Prospects
TLDR
Niosomes, which are nano-vesicles composed of non-ionic surfactants, are emerging nanocarriers in drug delivery applications due to their solution/storage stability and cost-effectiveness, and are biocompatible, biodegradable, flexible in structure, and suitable for loading both hydrophobic and hydrophilic drugs. Expand
SPANLASTICS-FUTURE OF DRUG DELIVERY AND TARGETING
Delivery of drugs to the targeted tissues is restricted by various barriers. Conventional drug delivery systems like solutions, suspensions, emulsions, tablets, capsules etc. have been devised forExpand
The Role of Surface Active Agents in Ophthalmic Drug Delivery: A Comprehensive Review.
  • S. S. Ibrahim
  • Computer Science, Medicine
  • Journal of pharmaceutical sciences
  • 2019
TLDR
This review provides a comprehensive analysis of the different functional roles of SAAs in novel ophthalmic drug delivery platforms, their mechanism of action, and limitations that need to be considered during formulation to maximize their potential benefit. Expand
SPANLASTICS: A MODERN APPROACH FOR NANOVESICULAR DRUG DELIVERY SYSTEM
Drug delivery to targeted sites is restricted by various barriers. The conventional drug delivery systems like tablets, capsules, suspensions, emulsions, elixirs, lotions etc. are being encounteredExpand
Nanovesicular Carrier Systems for Ophthalmic Drug Delivery
TLDR
Overall, nanovesicles for ophthalmic drug delivery are a promising approach to deliver both hydrophilic and hydrophobic drug candidates efficiently. Expand
Drug-Loaded Nanoparticles Embedded in a Biomembrane Provide a Dual-Release Mechanism for Drug Delivery to the Eye.
TLDR
The dual-release membrane system shows promise for a new drug delivery method to the eye with limited burst release and sustained delivery of medication, from both the nanoparticles and the membrane. Expand
An illustrated review on nonionic surfactant vesicles (niosomes) as an approach in modern drug delivery: Fabrication, characterization, pharmaceutical, and cosmetic applications
After the beginning of nanotechnology, nanomedicines have attracted great attention for more efficient and safe drug delivery. In this regard, a large number of studies have been allocated toExpand
Synthesis of biocompatible Triazole based non-ionic surfactant and its vesicular drug delivery investigation.
TLDR
Results of this study suggests that the newly synthesized triazole based surfactant can be used in drug delivery for improving bioavailability of less water soluble drugs like Amphotericin B. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 119 REFERENCES
Nanocarriers in ocular drug delivery: an update review.
TLDR
This review presents an overview of the various aspects of the ocular drug delivery, with special emphasis on nanocarrier based strategies, including structure of eye, its barriers, delivery routes and the challenges/limitations associated with development of novelnanocarriers. Expand
Cationic Vectors in Ocular Drug Delivery
TLDR
This review will focus on the formulation of three main representative cationic colloids developed for ophthalmic delivery: liposomes, emulsions and nanoparticles (NP). Expand
Vesicular systems in ocular drug delivery: an overview.
TLDR
The constraints with conventional ocular therapy are reviewed and various novel approaches, in general, to improve ocular bioavailability of the drugs, advantages of vesicular approach over these and the future challenges to render the vesicle system more effective are explored. Expand
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
  • Jim Jiao
  • Chemistry, Medicine
  • Advanced drug delivery reviews
  • 2008
TLDR
This review attempts to place in perspective the importance of polyoxyethylated nonionic surfactants in the design and development of topical ocular drug delivery systems by assessing their compatibility with common ophthalmic inactive ingredients, their impact on product stability, and their roles in facilitating ocular drugs to reach the target sites. Expand
Ophthalmic drug delivery systems—Recent advances
TLDR
Polymeric gels, colloidal systems, cyclodextrins and collagen shields have been developed as a new continuous-delivery system for drugs that provide high and sustained levels of drugs to the cornea, despite a problem of tolerance. Expand
Recent Perspectives in Ocular Drug Delivery
TLDR
Several ocular drug delivery systems such as microemulsions, nanosuspensions, nanoparticles, liposomes, niosomes, dendrimers, implants, and hydrogels are discussed. Expand
Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery
TLDR
The main aim of this article is to give an insight into the potential application of mucoadhesives and corneal penetration enhancers for the conception of innovative opthalmic delivery appraoches, to decrease the systemic side effects, and create a more focused effect, which may be achieved with lower doses of the drug. Expand
Nonionic surfactant vesicular systems for effective drug delivery—an overview
TLDR
All aspects of niosomes including their different compositions, the various methods of preparation, the effect of changing manufacturing parameters, methods of characterization, factors that affect their stability, their use by various routes of administration, their therapeutic applications and the most important patents are described. Expand
Ocular Preparations: The Formulation Approach
TLDR
The barriers that decrease the bioavailability of an ophthalmic drug; the objectives to be considered in producing optimal formulations; and the approaches being used to improve the corneal penetration of a drug molecule and delay its elimination from the eye are reviewed. Expand
Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery
TLDR
Investigation of the feasibility of using non-ionic surfactant vesicles (niosomes) as carriers for the ophthalmic controlled delivery of a water soluble local antibiotic; gentamicin sulphate found that niosomal formulations have exhibited a high retention of gentamic in sulphate inside the vesicle such that their in vitro release was slower compared to the drug solution. Expand
...
1
2
3
4
5
...